Massachusetts Financial Services CO Neuronetics, Inc. Transaction History

Massachusetts Financial Services CO

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2018 Oct 25, 2018	SELL	$24.32 - $37.54 $2.43 Million - $3.75 Million	-100,000 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$26.61 - $27.78 $2.66 Million - $2.78 Million	100,000 New	100,000 $2.66 Million

18.3M

3.8K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $23M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

Stay updated on Massachusetts Financial Services CO with notifications on news.